Free Trial

Lexeo Therapeutics (LXEO) Institutional Ownership

Lexeo Therapeutics logo
$5.02 +0.05 (+1.01%)
Closing price 04:00 PM Eastern
Extended Trading
$5.00 -0.01 (-0.30%)
As of 05:25 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Institutional Ownership Changes (13F Filings) for Lexeo Therapeutics (NASDAQ:LXEO)

Current
Institutional Ownership
Percentage
60.67%
Number of
Institutional Buyers
(last 12 months)
57
Total
Institutional Inflows
(last 12 months)
$105.32M
Number of
Institutional Sellers
(last 12 months)
17
Total
Institutional Outflows
(last 12 months)
$45.47M
Get LXEO Insider Trade Alerts

Want to know when executives and insiders are buying or selling Lexeo Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

LXEO Institutional Buying and Selling by Quarter

Lexeo Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/15/2025 Vestal Point Capital LP3,228,161$12.98M0.7%+184.1%9.723%
8/15/2025 Frazier Life Sciences Management L.P.4,424,725$17.79M0.7%+363.1%13.327%
8/15/2025 BNP Paribas Financial Markets48,434$195K0.0%+20.4%0.146%
8/15/2025 Bridgeway Capital Management LLC53,400$215K0.0%+39.1%0.161%
8/15/2025 Balyasny Asset Management L.P.4,009,137$16.12M0.0%N/A12.076%
8/15/2025 Bank of America Corp DE26,653$107K0.0%+22.4%0.080%
8/14/2025 Pale Fire Capital SE27,650$111K0.0%+46.3%0.083%
8/14/2025 Cerity Partners LLC12,447$50K0.0%N/A0.037%
8/13/2025 Affinity Asset Advisors LLC3,589,355$14.43M2.0%+142.4%10.812%
8/13/2025 Quadrature Capital Ltd29,779$120K0.0%N/A0.090%
8/8/2025 Intech Investment Management LLC13,682$55K0.0%+20.7%0.041%
8/8/2025 Geode Capital Management LLC578,081$2.33M0.0%-1.4%1.741%
8/6/2025 Savant Capital LLC29,667$119K0.0%N/A0.089%
7/30/2025 Ethic Inc.10,726$44K0.0%N/A0.032%
7/30/2025 Privium Fund Management B.V.178,356$753K0.2%+11.3%0.537%
7/25/2025 CWM LLC10,351$42K0.0%+150.3%0.031%
7/25/2025 Vanguard Personalized Indexing Management LLC15,000$60K0.0%N/A0.045%
7/15/2025 Palumbo Wealth Management LLC56,303$226K0.1%N/A0.170%
6/27/2025 Goldman Sachs Group Inc.79,108$275K0.0%-13.0%0.238%
5/29/2025 Rhumbline Advisers30,192$105K0.0%+19.8%0.091%
5/21/2025 Acadian Asset Management LLC24,648$85K0.0%N/A0.074%
5/16/2025 Woodline Partners LP837,014$2.90M0.0%-2.5%2.521%
5/16/2025 Goldman Sachs Group Inc.79,108$275K0.0%-13.0%0.238%
5/16/2025 Millennium Management LLC1,071,489$3.72M0.0%+654.8%3.228%
5/16/2025 AQR Capital Management LLC50,337$175K0.0%+370.0%0.152%
5/16/2025 Adage Capital Partners GP L.L.C.237,953$826K0.0%-89.2%0.717%
5/15/2025 Vestal Point Capital LP1,136,249$3.94M0.3%-5.3%3.423%
5/15/2025 DAFNA Capital Management LLC378,083$1.31M0.4%-3.8%1.139%
5/14/2025 Affinity Asset Advisors LLC1,480,881$5.14M0.5%N/A4.461%
5/13/2025 Ground Swell Capital LLC23,123$80K0.2%N/A0.070%
5/12/2025 Nuveen LLC36,050$125K0.0%N/A0.109%
5/9/2025 Charles Schwab Investment Management Inc.56,174$195K0.0%-12.1%0.169%
5/9/2025 Privium Fund Management B.V.160,198$556K0.1%+16.0%0.483%
3/24/2025 Wellington Management Group LLP76,981$507K0.0%+48.3%0.233%
2/18/2025 Frazier Life Sciences Management L.P.955,515$6.29M0.3%-23.6%2.889%
2/17/2025 Woodline Partners LP858,691$5.65M0.0%+0.8%2.597%
2/17/2025 Vestal Point Capital LP1,200,000$7.90M0.5%+41.2%3.629%
2/17/2025 Point72 Asset Management L.P.750,235$4.94M0.0%+102.5%2.269%
2/17/2025 Omega Fund Management LLC1,184,636$7.80M6.5%-49.7%3.582%
2/17/2025 Millennium Management LLC141,951$934K0.0%+282.5%0.429%
2/17/2025 Janus Henderson Group PLC4,339,254$28.51M0.0%+15.3%13.121%
2/17/2025 Deutsche Bank AG13,226$87K0.0%+172.8%0.040%
2/17/2025 DAFNA Capital Management LLC393,083$2.59M0.7%+56.9%1.189%
2/17/2025 Corton Capital Inc.13,771$91K0.1%N/A0.042%
2/17/2025 Bridgeway Capital Management LLC65,000$428K0.0%N/A0.197%
2/17/2025 Bank of America Corp DE30,376$200K0.0%-21.7%0.092%
2/17/2025 BNP Paribas Financial Markets34,527$227K0.0%+523.1%0.104%
2/17/2025 Allostery Investments LP5,054$33K0.0%N/A0.015%
2/14/2025 Jane Street Group LLC14,512$95K0.0%-59.3%0.044%
2/14/2025 Northern Trust Corp214,284$1.41M0.0%+7.1%0.648%
2/14/2025 Boothbay Fund Management LLC147,807$973K0.0%+37.5%0.447%
2/14/2025 D1 Capital Partners L.P.2,203,900$14.50M0.2%-12.1%6.664%
2/14/2025 Adage Capital Partners GP L.L.C.2,209,615$14.54M0.0%-14.9%6.682%
2/14/2025 Price T Rowe Associates Inc. MD10,425$69K0.0%N/A0.032%
2/14/2025 Altium Capital Management LLC405,000$2.67M0.8%N/A1.225%
2/13/2025 Marshall Wace LLP17,794$117K0.0%N/A0.054%
2/13/2025 Jump Financial LLC20,400$134K0.0%N/A0.062%
2/13/2025 Walleye Capital LLC61,930$407K0.0%N/A0.187%
2/13/2025 Barclays PLC55,161$363K0.0%+9.9%0.167%
2/13/2025 ADAR1 Capital Management LLC169,505$1.12M0.2%+196.5%0.513%
2/13/2025 Aristides Capital LLC29,285$193K0.0%N/A0.089%
2/13/2025 Wells Fargo & Company MN11,156$73K0.0%+49.9%0.034%
2/12/2025 Geode Capital Management LLC567,383$3.74M0.0%+2.6%1.716%
2/12/2025 Wellington Management Group LLP76,981$507K0.0%+48.3%0.233%
2/12/2025 JPMorgan Chase & Co.13,371$88K0.0%+30.1%0.040%
2/11/2025 Privium Fund Management B.V.138,115$909K0.2%N/A0.418%
2/4/2025 Bank of New York Mellon Corp50,660$333K0.0%+5.6%0.153%
1/30/2025 Rhumbline Advisers25,197$166K0.0%+19.6%0.076%
1/24/2025 China Universal Asset Management Co. Ltd.7,011$46K0.0%N/A0.021%
1/17/2025 SG Americas Securities LLC10,960$72K0.0%N/A0.033%
12/26/2024 JPMorgan Chase & Co.10,278$93K0.0%+135.6%0.031%
12/13/2024 Exome Asset Management LLC88,148$797K0.5%N/A0.267%
11/19/2024 Barclays PLC50,210$454K0.0%+162.2%0.152%
11/16/2024 Geode Capital Management LLC553,247$5.00M0.0%+86.5%1.673%
11/15/2024 Frazier Life Sciences Management L.P.1,250,786$11.31M0.5%N/A3.783%
11/15/2024 Barclays PLC50,210$454K0.0%+162.2%0.152%
11/15/2024 Jane Street Group LLC35,677$323K0.0%+33.3%0.108%
11/15/2024 Wellington Management Group LLP51,892$469K0.0%+134.8%0.157%
11/15/2024 State Street Corp253,946$2.30M0.0%+29.4%0.768%
11/15/2024 RA Capital Management L.P.546,554$4.94M0.1%-18.8%1.653%
11/15/2024 Point72 Asset Management L.P.370,407$3.35M0.0%N/A1.120%
11/15/2024 Polar Asset Management Partners Inc.59,800$541K0.0%-8.4%0.181%
11/15/2024 Ikarian Capital LLC257,216$2.33M0.3%N/A0.778%
11/15/2024 Jacobs Levy Equity Management Inc.30,346$274K0.0%N/A0.092%
11/15/2024 Janus Henderson Group PLC3,763,195$34.00M0.0%+18.9%11.383%
11/14/2024 PDT Partners LLC26,608$241K0.0%N/A0.080%
11/14/2024 Braidwell LP728,777$6.59M0.2%-47.3%2.204%
11/14/2024 Eventide Asset Management LLC1,855,986$16.78M0.3%-44.9%5.614%
11/14/2024 Verition Fund Management LLC777,320$7.03M0.0%+84.5%2.351%
11/14/2024 Vestal Point Capital LP850,000$7.68M0.6%+1.2%2.571%
11/14/2024 MetLife Investment Management LLC14,223$129K0.0%+121.5%0.043%
11/13/2024 BNP Paribas Financial Markets5,541$50K0.0%+184.2%0.017%
11/12/2024 Charles Schwab Investment Management Inc.63,874$577K0.0%+107.0%0.193%
10/24/2024 Novo Holdings A S1,122,581$10.15M0.5%-22.6%3.407%
10/23/2024 Values First Advisors Inc.7,446$67K0.0%N/A0.023%
8/20/2024 Novo Holdings A S1,450,500$23.27M1.2%-11.5%4.403%
8/1/2024 Rhumbline Advisers13,357$214K0.0%+37.3%0.041%
7/26/2024 Bank of New York Mellon Corp31,806$510K0.0%+12.3%0.097%
5/17/2024 RA Capital Management L.P.660,938$10.36M0.1%N/A2.006%
5/17/2024 Artal Group S.A.801,716$12.57M0.3%+32.9%2.434%
(Data available from 1/1/2016 forward)

LXEO Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of LXEO shares?

During the previous two years, 71 institutional investors and hedge funds held shares of Lexeo Therapeutics. The most heavily invested institutionals were Janus Henderson Group PLC ($28.51M), Frazier Life Sciences Management L.P. ($17.79M), Eventide Asset Management LLC ($16.78M), Balyasny Asset Management L.P. ($16.12M), D1 Capital Partners L.P. ($14.50M), Affinity Asset Advisors LLC ($14.43M), and Vestal Point Capital LP ($12.98M).Learn more on Lexeo Therapeutics' institutional investors.

What percentage of Lexeo Therapeutics' stock is owned by institutional investors?

60.67% of Lexeo Therapeutics' stock is owned by institutional investors. Learn more on LXEO's institutional investor holdings.

Which institutional investors have been buying Lexeo Therapeutics' stock?

Of the 65 institutional investors that purchased Lexeo Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Frazier Life Sciences Management L.P. ($4.72M), Balyasny Asset Management L.P. ($4.01M), Affinity Asset Advisors LLC ($3.59M), Eventide Asset Management LLC ($3.00M), Vestal Point Capital LP ($2.45M), Omega Fund Management LLC ($2.16M), and Janus Henderson Group PLC ($1.39M).

How much institutional buying is happening at Lexeo Therapeutics?

Institutional investors have bought a total of 20,550,500 shares in the last 24 months. This purchase volume represents approximately $105.32M in transactions.

Which of Lexeo Therapeutics' major shareholders have been selling company stock?

Of the 17 institutional investors that sold Lexeo Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Adage Capital Partners GP L.L.C. ($2.36M), Eventide Asset Management LLC ($1.51M), Omega Fund Management LLC ($1.17M), Braidwell LP ($653.70K), Novo Holdings A S ($327.92K), D1 Capital Partners L.P. ($302.71K), and Frazier Life Sciences Management L.P. ($295.27K).

How much institutional selling is happening at Lexeo Therapeutics?

Institutional investors have sold a total of 6,925,194 shares in the last 24 months. This volume of shares sold represents approximately $45.47M in transactions.



This page (NASDAQ:LXEO) was last updated on 9/5/2025 by MarketBeat.com Staff
From Our Partners